HomeAI · summaries
Storia in 4 fonti
FDA Gets New Avacopan Analysis After Alleging Data Manipulation
Agency has been calling for the vasculitis drug to be pulled from the market since January
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
VIDEO: Calabrese discusses FDA effort to withdraw avacopan approval, long COVID in ARDs
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage regarding the FDA’s effort to revoke its approval…
- ·
fiercepharma.com
Amgen hands in data package in hopes of FDA hearing for Tavneos defense
With all eyes on Tavneos’ seemingly precarious approval status in the U.S., Amgen is advancing plans to defend the ANCA-associated vasculitis (AAV) drug it inherited in its $3.7…
